Can MiniMed Group cover its short-term obligations?

Its current ratio is 1.59 — current assets exceed current liabilities.

Where does MiniMed Group 's balance sheet data come from?

Every line is extracted from MiniMed Group 's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

MiniMed Group MMED Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Cash and cash equivalents	$10M0.0%	——	——	$11M-79.6%	$10M—
Accounts receivable, net	$653M—	——	——	$570M—	——
Inventories	$408M+895%	——	——	$311M—	$41M—
Raw materials	$164M—	——	——	$87M—	——
Work in process	$44M—	——	——	$38M—	——
Finished goods	$199M—	——	——	$185M—	——
Prepaid expenses and other current assets	$37M—	——	——	$48M—	——
Total current assets	$1.11B—	——	——	$939M—	——
Property and equipment, net	$701M—	——	——	$706M—	——
Accumulated depreciation	$208M—	——	——	$188M—	——
Operating lease right-of-use assets	$60M—	——	——	$66M—	——
Goodwill	$2.26B—	——	——	$2.26B—	——
Intangible assets, net	$113M—	——	——	$132M—	——
Deferred tax assets	$19M—	——	——	$19M—	——
Other non-current assets	$146M—	——	——	$150M—	——
Equity method investments	$72M—	——	——	$73M—	——
Long-term investments	$75M—	——	——	$75M—	——
Total assets	$4.34B—	——	——	$4.2B—	——
Accounts payable	$303M—	——	——	$205M—	——
Accrued expenses	$17M—	——	——	$15M—	——
Deferred revenue	$13M—	——	——	$11M—	——
Operating lease liabilities, current	$11M—	——	——	$11M—	——
Contract liabilities	$4M—	——	——	$3M—	——
Other current liabilities	$78M—	——	——	$40M—	——
Total current liabilities	$696M—	——	——	$710M—	——
Operating lease liabilities, non-current	$50M—	——	——	$56M—	——
Other non-current liabilities	$184M—	——	——	$162M—	——
Total liabilities	$881M—	——	——	$871M—	——
Accumulated other comprehensive income (loss)	$14M—	——	——	$3M—	——
Total stockholders' equity	$3.46B-0.7%	$3.56B+2.8%	$3.54B+1.6%	$3.33B-3.4%	$3.49B—
Total liabilities and stockholders' equity	$4.34B—	——	——	$4.2B—	——
Allowance for Doubtful Accounts	$64M—	——	——	$46M—	——
Allowance for Doubtful Accounts Receivable (Current)	$64M—	——	——	$46M—	——
Finished goods	$199M—	——	——	$185M—	——
Other current assets	$37M—	——	——	$48M—	——
Trading Securities in Marketable Securities	$72M—	——	——	$73M—	——
Deferred Tax Assets and Other Non-Current Assets	$146M—	——	——	$150M—	——
Equity Securities Without Readily Determinable Fair Value - Cumulative Downward Adjustments	$72M—	——	——	$73M—	——
Finite-Lived Intangible Assets - Expected Amortization Expense (Year One)	$19M—	——	——	——	——
Finite Lived Intangible Assets - Gross	$320M—	——	——	$320M—	——
Investments - Amortized Cost Basis	$72M—	——	——	$73M—	——
Net Investment in Lease	$60M—	——	——	$66M—	——
Deferred tax assets	$19M—	——	——	$19M—	——
Other intangible assets—net	$113M—	——	——	$132M—	——
Investments	$75M—	——	——	$75M—	——
Operating lease right-of-use assets	$60M—	——	——	$66M—	——
Other non-current assets	$146M—	——	——	$150M—	——
Operating Lease Right-of-Use Assets in Other Assets	$60M—	——	——	$66M—	——
Software and Technology Licenses, Net	$146M—	——	——	$150M—	——
Accrued Contingent Liabilities	$11M—	——	——	$165M—	——
Accrued Manufacturing Costs	$184M—	——	——	$182M—	——
Accrued Progress Collections and Price Adjustments	$4M—	——	——	$3M—	——
Accrued Rebates, Returns, and Promotions	$48M—	——	——	$51M—	——
Contract Liabilities and Refund Liability	$7M—	——	——	$5M—	——
Compensation and benefits	$184M—	——	——	$182M—	——
Other accrued liabilities	$161M—	——	——	$271M—	——
Standard Product Warranty Accrual	$64M+12.3%	$60M0.0%	——	$57M-12.3%	$57M—
Supplier Finance Program Obligations	$19M—	——	——	$25M—	——
Contract Liabilities, Non-Current	$4M—	——	——	$3M—	——
Deferred revenue, net of current portion	$4M—	——	——	$3M—	——
Total debt	$61M—	——	——	$67M—	——
Net investment from Parent	$3.45B—	——	——	$3.33B—	——
Allowance for doubtful accounts	$64M—	——	——	$46M—	——
Ancillary services cost accrual	$12M—	——	——	$11M—	——
Contract termination accrual	$24M—	——	——	$0—	——
Contract with Customer, Liability	$17M—	——	——	$15M—	——
Customer refunds and credits	$48M—	——	——	$51M—	——
Contract with customer, refund liability	$48M—	——	——	$38M—	——
Estimated rate refund liabilities	$7M—	——	——	$5M—	——
Equity method investments (Note 11)	$2M—	——	——	$2M—	——
Trading securities, cost	$72M—	——	——	$73M—	——
Finite-Lived Intangible Assets, Accumulated Amortization	$208M—	——	——	$188M—	——
2028	$25M—	——	——	——	——
2030	$19M—	——	——	——	——
2031	$9M—	——	——	——	——
Remainder of 2026	$6M—	——	——	——	——
2027	$26M—	——	——	——	——
2029	$22M—	——	——	——	——
Gross Carrying Amount	$320M—	——	——	$320M—	——
Guarantor obligations, current carrying value	$78M—	——	——	$40M—	——
Loss Contingency Accrual	$11M—	——	——	$165M—	——
Other	$61M—	——	——	$53M—	——
Remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied	$23M—	——	——	——	——
Standard Product Warranty Accrual	$64M+12.3%	$60M0.0%	——	$57M-12.3%	$57M—
Supplier finance program, obligation	$19M—	——	——	$25M—	——
Remainder of Fiscal Year 2024	$6M—	——	——	——	——
Remainder of Fiscal Year 2025	$6M—	——	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Can MiniMed Group cover its short-term obligations?: Its current ratio is 1.59 — current assets exceed current liabilities.
Where does MiniMed Group 's balance sheet data come from?: Every line is extracted from MiniMed Group 's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.